Latest News

NEW: Guidelines & KT Tools… Plus a Sleek New Version of the iCCS App!

June 14, 2023

We are excited to officially launch a new resource called Guidelines & KT Tools, housed on the...

Guidelines iCCS KT Tools

Introducing CCS’s NEW Cardiorenal Pocket Guide

June 2, 2023

The Cardiorenal Risk Reduction in Adults Pocket Guide is now here! Pocket Guides are our most...

Cardiorenal Guidelines Pocket Guides

Two classes of glucose-lowering drugs reduce risk of heart failure, kidney complications and death – even in patients without type 2 diabetes

September 30, 2022

New Cardiorenal Protection Guideline urges use of GLP-1RA and SGLT2i drugs to save lives; as many as...

Cardiorenal Guidelines

2023 Call for CCS Guideline and Clinical Practice Update Topics – NOW LIVE!

September 16, 2022

CCS News Guidelines

Top 10 Takeaways

July 28, 2022

Top 10 Takeaways from the 2021 CCS Guidelines for the Management of Dyslipidemia for the Prevention...

Dyslipidemia Guidelines

Sweeping dyslipidemia guidelines urge improved screening, new medications, and lifestyle counselling. But, hold the fish-oil supplements.

July 28, 2022

Aggressive new approaches to reduce cholesterol-related heart disease are part of an extensive...

Dyslipidemia Guidelines

Guidelines to Inform Practice

May 10, 2022

The CCS turns 75: A proud past and a bright future

75th anniversary Guidelines

The CCS 2022 Peripheral Arterial Disease (PAD) Guidelines are here!

May 9, 2022

PAD is often asymptomatic, is underdiagnosed, under-recognized, and undertreated. It is also...

Guidelines PAD

Top 10 Takeaways

April 9, 2022

from the 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines...

Atrial Fibrillation Guidelines

Approved Guidelines/CPUs for Upcoming Cycle

April 5, 2022

The annual call for Guideline and Clinical Practice Update (CPU) topics received 28 high-quality...

Guidelines